Kaposi sarcoma

C3_KAPOSI_SARCOMA

Kaposi's sarcoma: A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 C46
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 C46
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

37

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

37

diagram downward connector

Check minimum number of events None

37

diagram downward connector

Include endpoints None

37

diagram downward connector
C3_KAPOSI_SARCOMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 C45-C49
Name in latin Sarcoma Kaposi

Summary Statistics

Key figures

All Female Male
Number of individuals 37 8 29
Unadjusted prevalence (%) 0.01 0.00 0.02
Mean age at first event (years) 65.52 62.92 66.23

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_KAPOSI_SARCOMA – Kaposi sarcoma
GWS hits:

Survival analyses between endpoints

Plot

before Kaposi sarcoma
after Kaposi sarcoma

loading spinner Loading survival analyses plot